CCL19 and disease arising from reactivation of latent virus: Since very low levels of CCL19 (10–100 nM) are required for priming of resting CD4+ T cells for latent infection with HIV [8], we used 30 and 100 nM of CCL19 for subsequent infection and immunoblotting experiments, respectively.